Uncategorised - European Medical Journal

Interpretation of the Cardiopulmonary Exercise Test

In this workshop held at ERS 2023, Piergiuseppe Agostoni guides the audience towards a deeper understanding of cardiopulmonary exercise…

Retracted: Highlights From the European Respiratory Society Congress 2023: Chronic Obstructive Pulmonary Disease and Severe Asthma

The sponsor of the below article (GSK) have requested its retraction in accordance with their internal compliance requirements following…

Evaluation of Bacteremia in Febrile Neutropenia and Implications on Antimicrobial Stewardship

Febrile neutropenia (FN) is a common complication in patients with cancer, and historically, pseudomonal infections have been attributed…

The 2022–2023 USA Respiratory Viral ‘Tripledemic’: Healthcare Lessons Learned

The convergence of three viral epidemics, respiratory syncytial virus (RSV), COVID-19, and influenza, during 2022–2023, placed a…

ADVENT Dermatology

ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron…

Review of IDWeek 2023

This year’s IDWeek, the joint annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology…

Interview: Shweta Anjan

TID is an exciting and rapidly expanding field. I began my career as a medical student at Kasturba Medical College in Manipal, India…

Review of the European Academy of Dermatology and Venereology (EADV) Congress 2023

BERLIN, Germany, was the setting for the 2023 European Academy of Dermatology and Venereology (EADV) Congress. With over 15,500 attendees…

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…

Efficacy and Improvement of Qualify of Life in Patients Treated with Brodalumab in Real Clinical Practice: A Case Series of 31 Patients

Brodalumab, a fully human recombinant monoclonal antibody of the IgG2 type, binds strongly to IL-17 receptor A,3 effectively inhibiting…